← Evidence map

TrialNature medicine2025

Effect of felzartamab on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies.

Matthias Diebold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 40301559